The MMR vaccine has a strong safety record backed by decades of monitoring and studies involving millions of children. Most people who receive it experience no serious problems. Like any vaccine, it can cause mild side effects, and in very rare cases, more significant reactions. But the risks from the vaccine are far smaller than the risks from measles, mumps, or rubella themselves.
Common Side Effects
The MMR vaccine is a live attenuated vaccine, meaning it contains weakened versions of the three viruses. Because of this, your immune system mounts a real response, which can produce mild symptoms in the days following the shot. The most common reactions include soreness at the injection site, a low-grade fever, and occasionally a mild rash. These typically appear within a week or two and resolve on their own within a few days.
Some children develop a higher fever, which in rare cases can trigger a febrile seizure. Studies show a small increased risk of febrile seizures during the 5 to 12 days after the first MMR dose. Febrile seizures look alarming but are generally not harmful and don’t cause lasting effects. They’re a response to the fever itself, not to the vaccine directly affecting the brain.
Rare but Serious Reactions
The most well-documented rare reaction is a temporary bleeding disorder called immune thrombocytopenic purpura (ITP), where platelet counts drop and bruising or bleeding becomes more likely. The risk is about 1 in 22,300 doses, and most cases resolve without treatment within a few weeks.
Encephalitis, or inflammation of the brain, is another concern people ask about. With the vaccine, the estimated maximum risk is around 1 in a million doses. Compare that to natural measles infection, where about 2 in every 1,000 children develop encephalitis, which can result in permanent brain damage or death. The difference in risk is enormous.
Severe allergic reactions (anaphylaxis) are possible but extremely rare with any vaccine. They almost always happen within minutes of the injection, which is why clinics ask you to wait briefly afterward.
How Vaccine Risks Compare to Measles
The clearest way to understand MMR safety is to compare what happens in a group of 100 unvaccinated children who catch measles versus 100 children who get the vaccine. Among the children with measles, roughly 9 will develop pneumonia, 5 may get measles croup, and 1 may have a fever-induced convulsion. That’s 15 out of 100 with serious complications. On top of that, about 2 in 1,000 will develop encephalitis, and 1 in 100,000 will develop a fatal degenerative brain condition called SSPE years later.
Among the 100 vaccinated children, the serious complication rate is vanishingly small. The risk of encephalitis drops from 2 in 1,000 (with measles) to a maximum of 1 in a million (with the vaccine). The risk of the bleeding disorder drops from 3 in 1,000 to 26 in a million. And SSPE, the fatal brain disease? It simply doesn’t occur from the vaccine.
The MMR and Autism Question
The claim that MMR causes autism originated from a 1998 study that was later retracted due to serious ethical violations and scientific fraud. Since then, multiple large-scale studies have found no link. A JAMA study of 95,727 children, including nearly 2,000 who had an older sibling with autism spectrum disorder (the group you’d expect to show a connection if one existed), found no association between MMR vaccination and autism risk, even with two doses. The CDC and the American Academy of Pediatrics agree that the MMR vaccine is not responsible for increases in autism diagnoses.
How Safety Is Monitored
The MMR vaccine doesn’t just get approved and forgotten. Two major systems in the U.S. track its safety continuously. The Vaccine Adverse Event Reporting System (VAERS), run jointly by the CDC and FDA, acts as an early warning system. Healthcare providers are required by law to report certain adverse events, and anyone, including parents, can submit a report. VAERS is designed to detect unusual patterns that might signal a new problem.
The Vaccine Safety Datalink (VSD) is the more rigorous companion system. It draws on medical records from large healthcare organizations to conduct rapid, controlled studies when a potential safety signal emerges. Unlike VAERS, which collects unverified reports, the VSD can pull inpatient records, lab results, and pharmacy data to confirm or rule out a real risk. Together, these systems mean that even very rare problems are likely to be caught and investigated.
Who Should Not Get the MMR Vaccine
A small number of people have genuine medical reasons to avoid the MMR vaccine. Because it contains live weakened viruses, it’s not recommended for people with severe immunodeficiency, including those undergoing chemotherapy, those on long-term immunosuppressive therapy, or those with HIV who are severely immunocompromised. Pregnant women should also wait, since the theoretical risk to the fetus hasn’t been ruled out.
Other contraindications include a previous severe allergic reaction to a dose or a vaccine component (the vaccine contains small amounts of gelatin and the antibiotic neomycin), a history of the bleeding disorder ITP, and a first-degree family history of congenital immunodeficiency unless the child’s own immune function has been confirmed. If you’re moderately or severely ill, the recommendation is to wait until you’ve recovered. People who’ve recently received a blood product containing antibodies may also need to delay vaccination by up to 11 months, since those antibodies can interfere with the vaccine’s effectiveness.
The Recommended Schedule
Children typically receive two doses: the first between 12 and 15 months of age, and the second between ages 4 and 6, before starting school. The second dose can be given earlier if needed, as long as it’s at least 28 days after the first. Two doses provide about 97% protection against measles.
Most adults need just one dose unless they have specific risk factors, such as working in healthcare or traveling internationally, in which case two doses are recommended. Adults born before 1957 are generally considered immune because widespread circulation of these viruses before that time means they were almost certainly exposed naturally. There is no catch-up recommendation for a second dose among adults who already have one.